As of 2024-12-14, the Fair Value of Biosergen AB (BIOSGN.ST) is -0.95 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.61 SEK, the upside of Biosergen AB is -255.23%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | - | 5Y Avg | |
| Net income | -34.32 | -39.91 | -27.04 | - | -33.75 | |
| YoY growth | -410.38% | -16.28% | 32.25% | - | -131.47% | |
| Market Cap (mil) | 87.43 |
| P/E | |
| Forward P/E |
| EPS | -0.19 |
| Avg earnings growth rate | -131.47% |
| TTM earnings | -27.14 |